C1

Established in 2017, we're a customer-focused, sovereign Australian company built on trust, ethics, and collaboration. Our local, industry-qualified workforce works closely with clients to deliver secure, mission-ready ICT solutions that protect critical assets from evolving threats. We're an Australian veteran-owned company delivering ICT, Cyber, and Digital solutions and services across Defence, Government, Space, Emergency Services, and Critical Infrastructure. As a Veteran Employer of Choice, we understand the value of skills and experience gained through service and have developed a Veteran Careers Development Program to support transitioning ADF members and their partners.

Rearc is a boutique, engineering-driven services firm founded in 2016 by former Dow Jones and Wall Street Journal engineers who led a landmark three-year cloud transformation journey. This experience sparked the vision for a company that could bring enterprise-grade cloud expertise to organizations navigating complex digital transformations. Today, Rearc empowers builders to drive innovation through small, sharp teams that deliver outsized impact - combining deep technical expertise with a genuine care for people and customers. The company specializes in three core areas: Cloud, Data, and Generative AI. As an AWS Advanced Partner and Databricks Delivery Partner, Rearc helps enterprises accelerate their cloud and AI development efforts through services like Cloud Platform Engineering, Data Platform Foundation, Secure Data Collaboration, and GenAI Quickstart programs. Their engineering mindset focuses on creative problem-solving and sustainable outcomes, partnering closely with customers from strategy through implementation. With team members across multiple continents and a culture rooted in work-life harmony, Rearc has built trust with customers including Guardian Life Insurance, Bloomberg L.P., Avesis, and Moderna by consistently delivering technical excellence in regulated enterprise environments.

C2 Labs is a Service-Disabled Veteran-Owned Small Business trusted by over 100 organizations and institutions to revolutionize compliance through automated data collection, machine-readable documentation, AI-driven insights, and dynamic dashboards. The company partners with clients on their IT transformation journey via industry-leading capabilities in full stack development, hyper automation/DevOps, cybersecurity compliance, ISSO as a Service, and FedRAMP Enablement. C2 Labs enables organizations to innovate with speed and scale seamlessly while maintaining a robust and effective security posture. As digital transformation partners, C2 Labs addresses the most urgent needs holding back clients including proactively addressing cultural change, quantifying risk, automating compliance paperwork, and addressing critical skill gaps. The company specializes in cybersecurity risk and compliance, AI business strategies, and ATO-as-a-Service, providing advisory services to Cloud Service Providers seeking authorization under various compliance frameworks. By leveraging automation and partnerships with proven products like RegScale, C2 Labs frees organizations from bureaucracy and delivers continuously compliant solutions that drive real business impact.

F5, Inc. stands as the global leader in application delivery and security, delivering and securing applications across hybrid, multi-cloud, SaaS, and edge environments for the world's most critical digital experiences. Since 1996, F5 has evolved from a pioneering application delivery networking company into the premier platform that converges security, availability, and performance - trusted by over 80% of the Fortune 500 to protect their most valuable assets. The company's journey began with a simple yet powerful insight: as applications became the lifeblood of business, the tools designed to deliver them needed to be smarter, faster, and more secure. Today, F5's Application Delivery and Security Platform (ADSP) provides organizations with unified management, rich analytics, and fully programmable data planes that reduce blind spots, strengthen defenses, and drive better business outcomes. From its Seattle headquarters, F5 continues to innovate for the AI era, helping customers navigate the complexities of modern infrastructure while maintaining the security and performance their businesses depend on.

CMA CGM is a world leader in transport and logistics, serving more than 420 ports across five continents with a fleet of over 650 vessels. With annual revenue of $56 billion and operations in 160 countries, the Group employs more than 155,000 people worldwide through its network of 400 offices and 750 warehouses. As the third-largest shipping company globally, CMA CGM carries goods across the world's oceans, connecting businesses and communities through its comprehensive sea, land, air, and logistics solutions. Under the leadership of Chairman and CEO Rodolphe Saadé, the company continues to innovate and expand its global reach while maintaining its family business heritage. CMA CGM has committed to becoming Net Zero Carbon by 2050, pioneering the use of alternative fuels in shipping. Through its subsidiaries CEVA Logistics and CMA CGM AIR CARGO, the Group provides end-to-end supply chain services, demonstrating its ability to deliver comprehensive solutions that drive international trade and economic growth worldwide.

Clario is a leading healthcare research and technology company that generates high-quality clinical evidence for pharmaceutical, biotechnology, and medical device partners. Formerly known as ERT and Bioclinica, Clario brings over 50 years of expertise to clinical trial management. The company fuses deep scientific knowledge with global scale to deliver the broadest endpoint technology platform available. Clario has supported nearly 900 regulatory approvals across 19,000 studies spanning almost 600 indications, demonstrating a proven track record of accelerating drug development and reducing trial risk. Clario's comprehensive solutions span cardiac safety, electronic clinical outcome assessments (eCOA), medical imaging, precision motion, respiratory endpoints, and clinical adjudication. The company supports decentralized, hybrid, and site-based trials with advanced cloud-native technologies and AI-powered tools. With a presence in more than 80,000 sites worldwide, Clario's science-informed approach ensures the richest evidence possible for life-changing therapies. Their mission is to transform lives by unlocking better evidence, uniting clinical science, innovative technology, and global expertise to bring new treatments to patients faster.